News

Court Denies CVS’s Motion To Escape Discrimination Lawsuit Brought By HIV-Positive “John Doe” Plaintiffs, Says Consumer Watchdog

SAN FRANCISCO, July 31, 2023 /PRNewswire/ — Late Friday a federal court in San Francisco allowed a case brought by HIV-positive “John Doe” plaintiffs against CVS to proceed, denying CVS’s third motion to dismiss the […]

News

Wilson Sonsini Adds Karen Deschaine as a Partner in San Diego as the Firm Continues to Grow Its Corporate Life Sciences Practice

PALO ALTO, Calif.–(BUSINESS WIRE)–Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, announced today that Karen Deschaine has joined the firm’s corporate department as a […]

News

FibroGen limits rare-disease drug’s access after clinical trial failure. Some parents say it was saving their kids’ lives

‘How long before my heart fails?’ Tanner Edwards asked his mom after losing access to a FibroGen drug he’s taken for six years for Duchenne muscular dystrophy. Click here to view original post

News

Qylur Intelligent Systems Awarded U.S. Air Force SBIR Phase I Contract, Taps into Dual-Use Autonomous AI Market

SUNNYVALE, Calif.–(BUSINESS WIRE)–Qylur has been awarded a phase I Small Business Innovation Research contract from the Department of Defense Air Force for its SNIM® AI platform. Click here to view original post

News

Nylas’ New Generative AI Research Highlights How Developers Are Harnessing Tools Like ChatGPT, Bard, and Copilot

SAN FRANCISCO–(BUSINESS WIRE)–Nylas, the state-of-the-art communications platform giving developers universal access to email, calendar, and contacts providers through a single API integration, today released its new report focused on how developers and business leaders are […]

News

Biogen’s $7.3B M&A deal, layoffs; R&D shakeup at Pfizer, AstraZeneca; Scaling rare disease meds; Q2 earnings; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up […]